Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., commonly referred to as Sinopep, is a leading player in the biopharmaceutical industry, headquartered in Jiangsu, China. Established in 2003, the company has made significant strides in the development and production of innovative biopharmaceutical products, focusing on areas such as peptide synthesis and drug formulation. Sinopep's core offerings include a range of high-quality peptides and biologics, distinguished by their advanced manufacturing processes and commitment to research and development. The company has positioned itself as a trusted partner in the global pharmaceutical market, catering to both domestic and international clients. With a strong emphasis on quality and innovation, Sinopep has achieved notable milestones, solidifying its reputation as a key contributor to the biopharmaceutical landscape. Its dedication to excellence continues to drive its growth and influence within the industry.
DitchCarbon Score
How does Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s score of 10 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s reported carbon emissions
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate pledges outlined by the company at this time. In the context of the biopharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While Jiangsu Sinopep-Allsino may not have publicly stated its commitments or targets, the industry trend suggests a growing emphasis on sustainability and environmental responsibility. As the company moves forward, it may consider establishing measurable climate commitments and reduction initiatives to align with global standards and expectations in the biopharmaceutical sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
